Feature|Articles|November 15, 2024
- Pharmaceutical Executive: November 2024
- Volume 44
- Issue 11
Pharmaceutical Executive: November 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 1 year ago
AI’s Attention Spanover 1 year ago
Noam Solomon: Bringing the Human Story to AIover 1 year ago
ROI and Rare Disease: Retooling the ‘Gene’ Value Machineover 1 year ago
The Leap Forward: Practical Gains for Pharma AI Useover 1 year ago
Powering Pipelines Forward: Approach Science Differentlyover 1 year ago
Navigating the Current Landscape for Pharma Leadersover 1 year ago
Passage to Asia: Early Access for Innovative Therapiesalmost 2 years ago
Digital Protection: Q&A with Jeffrey BernsteinAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report
2
Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma
3
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
4
FDA Announces Seven Participants to PreCheck Pilot Program
5